The group’s principal activities include developing, manufacturing and commercializing medical products. The group products sold under the trade names SILCRYST(TM) and Acticoat(TM). Specific customer of the group is Smith and Nephew. The group operates from the United States and Canada. The revenue of the group for the year 2006 was 24,369 (thousands).
Executive Information
Name
Title
Email
Barry Heck
Chmn.
N/A
Eliot Lurier
CFO, VP - Finance, Administration
N/A
Paul Schechter
VP - Drug Development, Regulatory Affairs, Chief Medical Officer
